Press release
Actinic Keratosis Market Size in the 7MM is Expected to Grow by 2032 | DelveInsight
Actinic Keratosis Market
Key Takeaways from the Actinic Keratosis Market Report
• The increase in Actinic Keratosis Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Actinic Keratosis market is anticipated to witness growth at a considerable CAGR.
• The leading Actinic Keratosis Companies working in the market include Novartis AG, GlaxoSmithKline plc., Almirall, LLC, LEO Pharma Inc., Cipher Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, Bausch Health Companies Inc., Pierre Fabre Pharmaceuticals, Inc., and others.
• Promising Actinic Keratosis Pipeline Therapies in the various stages of development include KX01 ointment 1%, Solaraze, Diclofenac Sodium Gel, Solaraze 3% Topical Gel, PEP005 Gel, and others.
• March 2024: Infectopharm Arzneimittel GmbH announced a study of Phase 3 clinical trials for Solcera and Solaraze. The KOHDIAK study is a prospective, three-armed, randomised, double-blind study to evaluate the efficacy and safety of the treatment of mild and moderate actinic keratosis with a 5% potassium hydroxide solution (Solcera, medical device) versus placebo and investigator-blinded comparison with 3% diclofenac gel (Solaraze, medicinal product). It is performed in accordance with both the laws in force for clinical trials with medical devices and those with medicinal products.
• February 2024: Galderma Laboratorium GmbH- The objective of this non-interventional study (NIS) is to gain comprehensive insights into the practicability of ADL-PDT with Metvix® in patients with actinic keratoses under real-world conditions.
Discover which therapies are expected to grab the Actinic Keratosis Market Share @ Actinic Keratosis Market Outlook- https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Actinic Keratosis Overview
Actinic keratosis (AK), also known as solar keratosis, is a common skin condition characterized by rough, scaly patches or lesions that develop on sun-exposed areas of the skin. These areas are typically affected by long-term exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds.
Actinic Keratosis Epidemiology Insights
The epidemiology section of Actinic Keratosis offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Actinic Keratosis Epidemiology trends @ Actinic Keratosis Epidemiological Insights- https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Actinic Keratosis Drugs Market
The Actinic Keratosis Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Actinic Keratosis signaling in Actinic Keratosis are likely to uncover new therapeutic targets and further expand treatment options for patients.
Actinic Keratosis Treatment Market Landscape
The Actinic Keratosis treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Actinic Keratosis has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To know more about Actinic Keratosis treatment guidelines, visit @ Actinic Keratosis Treatment Market Landscape- https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Actinic Keratosis Market Outlook
The report's outlook on the Actinic Keratosis market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Actinic Keratosis therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Actinic Keratosis drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Actinic Keratosis market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.
Actinic Keratosis Drugs Uptake
The drug chapter of the Actinic Keratosis report provides a comprehensive analysis of marketed and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Actinic Keratosis.
Major Actinic Keratosis Companies
Several companies working in the market include Novartis AG, GlaxoSmithKline plc, Almirall, LLC, LEO Pharma Inc., Cipher Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, Bausch Health Companies Inc., Pierre Fabre Pharmaceuticals, Inc., and others
Learn more about the FDA-approved drugs for Actinic Keratosis @ Drugs for Actinic Keratosis Treatment- https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Actinic Keratosis Market Research Report
• Coverage- 7MM
• Study Period- 20190-2032
• Actinic Keratosis Companies- Novartis AG, GlaxoSmithKline plc., Almirall, LLC, LEO Pharma Inc., Cipher Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Biofrontera, Nestle SA, Bausch Health Companies Inc., Pierre Fabre Pharmaceuticals, Inc., and others.
• Actinic Keratosis Pipeline Therapies- KX01 ointment 1%, Solaraze, Diclofenac Sodium Gel, Solaraze 3% Topical Gel, PEP005 Gel, and others.
• Actinic Keratosis Market Dynamics: Actinic Keratosis Market Drivers and Barriers
• Actinic Keratosis Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Actinic Keratosis Drugs in development @ Actinic Keratosis Clinical Trials Assessment- https://www.delveinsight.com/sample-request/actinic-keratosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Actinic Keratosis
3. Competitive Intelligence Analysis for Actinic Keratosis
4. Actinic Keratosis: Market Overview at a Glance
5. Actinic Keratosis: Disease Background and Overview
6. Patient Journey
7. Actinic Keratosis Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Actinic Keratosis Unmet Needs
10. Key Endpoints of Actinic Keratosis Treatment
11. Actinic Keratosis Marketed Products
12. Actinic Keratosis Emerging Therapies
13. Actinic Keratosis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Actinic Keratosis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
List of Other Important Links-
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Vascular Grafts Market- https://www.delveinsight.com/report-store/vascular-grafts-market
Acne Vulgaris Market- https://www.delveinsight.com/report-store/acne-vulgaris-av-market
Bone Growth Stimulator Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Angiofibroma Market- https://www.delveinsight.com/report-store/angiofibroma-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Ascites Market- https://www.delveinsight.com/report-store/ascites-market
Systemic Lupus Erythematosus Market- https://www.delveinsight.com/report-store/systemic-lupus-erythematosus-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Cxcr Inhibitors Market- https://www.delveinsight.com/report-store/c-x-c-chemokine-receptor-inhibitors-competitive-landscape-market-and-pipeline-analysis
Androgen Receptor Inhibitor Market- https://www.delveinsight.com/report-store/androgen-receptor-inhibitor-market-forecast
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
STS Devices Market- https://www.delveinsight.com/report-store/sts-devices-market
Positive Airway Pressure Device Market- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Actinic Keratosis Market Size in the 7MM is Expected to Grow by 2032 | DelveInsight here
News-ID: 3513573 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Actinic
Actinic Keratosis Market Emerging Trends and Growth Prospects 2034
Introduction
Actinic keratosis (AK), also known as solar keratosis, is one of the most common precancerous skin conditions caused by long-term ultraviolet (UV) radiation exposure. It primarily affects older adults with fair skin and is considered a precursor to squamous cell carcinoma, making early detection and treatment critical. With rising awareness of skin cancer prevention, growing dermatology consultations, and expanding therapeutic innovations, the global actinic keratosis market is experiencing significant growth.
Over…
Global Actinic Keratosis Market Report Forecast to 2027
A rough, scaly area on the skin called an actinic keratosis Market develops after years of sun exposure. It commonly appears on the cheeks, lips, ears, forearms, scalp, neck, and backs of the hands. An actinic keratosis, also known as a sun keratosis, develops slowly and generally appears in persons over the age of 40. By limiting your sun exposure and protecting your skin from ultraviolet (UV) radiation, you…
Actinic Keratosis Market Insight, Epidemiology and Market Forecast -2026
The report studies the global Actinic Keratosis Market with many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. The report offers valuable insight into the Actinic Keratosis Market progress and approaches related to the market with an analysis of each region. The report goes on to…
Actinic Keratosis Treatment Market To Increase at Steady Growth Rate
Actinic keratosis (AK) is a form of skin cancer and it is also known as solar keratosis. This indication tends to affect the sun-exposed parts of the skin such as face, bald scalp, lips, and the back of the hands among others. As a result of the exposure, the skin tends to become rough, uneven and display a warty look. Approximately, 10% of the exposed areas tend to develop squamous…
United States Actinic Keratosis Treatment Market Report 2016
MarketResearchReports.biz has recently announced the addition of a market study “ United States Actinic Keratosis Treatment Market Report 2016 ”, is a comparative analysis of the global market.
Notes:
Sales, means the sales volume of Actinic Keratosis Treatment
Revenue, means the sales value of Actinic Keratosis Treatment
This report studies sales (consumption) of Actinic Keratosis Treatment in United States market, focuses on the top players, with sales, price, revenue and market…
Actinic Launches Ecommerce Fraud Checking Service with The 3rd Man
West Byfleet, Surrey – 3 June 2009 – With research showing consumers increasingly worried about card security when shopping online, Actinic (www.actinic.co.uk), the UK expert in ecommerce for small and medium businesses, has responded to the challenge with a major enhancement to its Actinic Payments service for combating card-not-present (CNP) fraud. Actinic Payments’ merchants now have seamless access to the anti-fraud, card verification service from The 3rd Man for no…
